NEW YORK, Dec. 11, 2012 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (TGTX), an innovative, clinical-stage biopharmaceutical company focused on the acquisition, development and commercialization of medically important pharmaceutical products for the treatment of cancer and other underserved therapeutic needs, today announced that Michael Weiss, the Company's Executive Chairman and Interim Chief Executive Officer, will be presenting at the Oppenheimer 23rd Annual Healthcare Conference, being held at the Waldorf Astoria in New York City. Mr. Weiss' presentation is scheduled to take place on Thursday December 13, 2012 at 3:20 PM ET. A webcast of this presentation will be available at www.tgtxinc.com on the events page under the Investors & Media section.